NIAID animation explains the ever-changing nature of influenza viruses.
Learn how immunizing a critical portion of a community protects most members of the community.
Volunteer for NIAID-funded clinical studies related to vaccines on ClinicalTrials.gov.
Vaccines provide safe, cost-effective, and efficient means of preventing illness, disability, and death from infectious diseases. NIAID conducts and supports research on new and improved vaccines and is a worldwide leader in the basic immunology research that underpins all vaccine research and development.
Two-Dose Rotavirus Vaccine Regimen Initiated During Newborn Period Prevents Rotavirus Diarrhea
Rabies Vaccine Protects Nonhuman Primates against Deadly Ebola Virus
TB Vaccine Development: Engineered Autophagy Boosts BCG Protective Immunity May Result in New Strategies for TB Vaccine Development
Jordan Report: Accelerated Development of Vaccines 2012
Videocast: HHS Science Seminar for Media—Advances in Influenza Vaccine Technologies
NIAID Network of Vaccine and Treatment Evaluation Units (VTEUs)
NIAID Lab Developing Intranasal RSV Vaccines
NIAID Scientists Use Reverse Genetics to Develop Potential Dengue Vaccine
Flu Shots No More? NIAID Grantees Use New Skin Patches to Deliver Flu Vaccine in Mice
Research to Advance Vaccine Safety (R01 and R21)
NIH Scientists Develop Candidate Vaccine Against Respiratory Syncytial Virus—Oct. 31, 2013
NIH Expands Nationwide Network of Vaccine and Treatment Evaluation Units—Sept. 26, 2013
Investigational Malaria Vaccine Found Safe and Protective—Aug. 8, 2013
Media Availability: NIH Scientists Identify Protective Role for Antibodies in Ebola Vaccine Study—Jan. 14, 2013
All vaccine news and events
News from NIAID-Supported Institutions
Last Updated August 08, 2013